滝沢 翼

Medicine & Life Sciences

1. Migraine Disorders 100%
2. Cortical Spreading Depression 84%
3. Headache 54%
4. Optogenetics 52%
5. Trigeminal Ganglion 32%
6. Myasthenia Gravis 31%
7. Cluster Headache 24%
8. Vagus Nerve Stimulation 24%
9. Neurons 21%
10. Vaccination 21%
11. Calcitonin Gene-Related Peptide 21%
12. galcanezumab 20%
13. Intracranial Aneurysm 19%
14. (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate 19%
15. Hyperalgesia 18%
16. ubrogepant 18%
17. lasmiditan 18%
18. olcegepant 17%
19. Capsaicin 17%
20. Japan 16%
21. Photophobia 15%
22. Rupture 15%
23. Single-Photon Emission-Computed Tomography 15%
24. Infarction 15%
25. Potassium 14%
26. Anti-N-Methyl-D-Aspartate Receptor Encephalitis 14%
27. Inosine Monophosphate 14%
28. Sumatriptan 13%
29. Neurovascular Coupling 13%
30. Snow 13%
31. SARS Virus 13%
32. Primary Dysautonomias 13%
33. Primary Headache Disorders 12%
34. Caveolins 12%
35. Therapeutics 12%
36. Coronavirus 12%
37. Neuromyelitis Optica 12%
38. Transcytosis 12%
39. Thyroiditis 12%
40. Vasopressin Receptors 11%
41. Aneurysm 11%
42. Phenylketonurias 11%
43. Estrous Cycle 11%
44. rho-Associated Kinases 11%
45. Thymoma 10%
46. Visual Fields 10%
47. Brain Injuries 10%
48. Mycobacterium bovis 9%
49. Nerve Growth Factor 9%
50. Genetic Background 9%